Physician
Shoals Primary Care, LLC
Shoals Primary Care, LLC was paid $5.78M by Medicaid between Jan 2018 and Nov 2024, across 119 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 63% of everything it billed.
33Billing provider infoSHOALS PRIMARY CARE, LLC
SHEFFIELD, AL 35660
SHEFFIELD, AL 35660
33aNPI1326373861assigned 10/15/2009
33bProvider typeInternal Medicine Physician
28Total paid$5.78M
24GClaims222,399
24DCodes billed119
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Internal Medicine Physician providers in Alabama
Rank by total paid#1 of 225
Median peer was paid$17K
This provider vs. median335×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 52,425 | $651K | |
| 2019 | 33,275 | $716K | |
| 2020 | 24,963 | $832K | |
| 2021 | 28,880 | $987K | |
| 2022 | 28,933 | $971K | |
| 2023 | 35,169 | $1000K | |
| 2024incomplete | 18,754 | $629K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 63% | 85,566 | 64,009 | $3.64M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 24,832 | 19,176 | $867K |
| 80050 | General health panel | 6.5% | 8,977 | 8,202 | $375K |
| 80061 | Lipid panel | 2.0% | 9,500 | 8,671 | $114K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.4% | 4,052 | 1,475 | $84K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 15,584 | 10,389 | $77K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 1.1% | 412 | 357 | $61K |
| 92587 | <1% | 1,527 | 1,277 | $45K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 437 | 192 | $39K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 519 | 421 | $39K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 140 | 127 | $32K |
| 99243 | <1% | 323 | 270 | $31K |
107 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,010 | $30K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,228 | $29K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,925 | $26K |
| 99490 | Ccm add 20min | <1% | 8,788 | $25K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,463 | $19K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 367 | $18K |
| 82607 | <1% | 1,273 | $17K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 665 | $16K |
| 93000 | <1% | 1,583 | $15K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 826 | $14K |
| 82746 | <1% | 1,230 | $13K | |
| 82728 | <1% | 1,109 | $12K | |
| 87428 | <1% | 318 | $10K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,164 | $10K |
| 80053 | Comprehensive metabolic panel | <1% | 974 | $10K |
| 83550 | <1% | 1,097 | $9K | |
| 99223 | Prolong inpt eval add15 m | <1% | 125 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 549 | $7K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 134 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 679 | $6K |
| 83540 | <1% | 1,111 | $6K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 321 | $6K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 123 | $6K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 49 | $5K |
| 84481 | <1% | 339 | $5K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 276 | $5K |
| 92550 | <1% | 456 | $4K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 707 | $4K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 49 | $4K |
| 70220 | <1% | 273 | $4K | |
| 90674 | <1% | 297 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 167 | $2K |
| 83735 | <1% | 400 | $2K | |
| 84436 | <1% | 349 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 490 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,343 | $2K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 33 | $2K |
| 84479 | <1% | 349 | $2K | |
| 72110 | <1% | 90 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 32 | $1K |
| 81003 | <1% | 386 | $1K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 126 | $747.39 |
| 71045 | Radiologic examination, chest; single view | <1% | 99 | $738.08 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 21 | $728.00 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 16 | $676.06 |
| 73560 | <1% | 69 | $644.17 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 609 | $616.22 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 15 | $610.54 |
| 90661 | <1% | 34 | $601.83 | |
| 0012A | <1% | 13 | $520.00 | |
| 93880 | <1% | 20 | $515.77 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 129 | $515.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 746 | $487.99 |
| 99457 | <1% | 96 | $460.80 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,487 | $456.03 |
| 73562 | <1% | 68 | $416.00 | |
| 84550 | <1% | 72 | $384.00 | |
| 80305 | <1% | 79 | $368.99 | |
| 94729 | <1% | 27 | $331.40 | |
| 94727 | <1% | 27 | $265.00 | |
| 90756 | <1% | 153 | $236.85 | |
| 82962 | <1% | 98 | $234.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 38 | $224.00 |
| 99454 | <1% | 47 | $210.71 | |
| 81002 | <1% | 80 | $131.61 | |
| 84439 | <1% | 15 | $117.00 | |
| 94010 | <1% | 12 | $100.93 | |
| 83690 | <1% | 18 | $84.00 | |
| 82150 | <1% | 18 | $84.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 29 | $82.48 |
| 82043 | <1% | 13 | $78.00 | |
| 99173 | <1% | 22 | $52.00 | |
| 3078F | 0% | 3,952 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 582 | $0.00 |
| 4004F | 0% | 1,318 | $0.00 | |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 233 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 7,029 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 59 | $0.00 |
| 4040F | 0% | 689 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 415 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 1,198 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 263 | $0.00 |
| 3016F | 0% | 120 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 26 | $0.00 |
| 4025F | 0% | 15 | $0.00 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 0% | 34 | $0.00 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 31 | $0.00 |
| G8399 | Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed | 0% | 32 | $0.00 |
| 92502 | 0% | 12 | $0.00 | |
| 3077F | 0% | 12 | $0.00 | |
| 99307 | 0% | 20 | $0.00 | |
| 3074F | 0% | 4,859 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 1,408 | $0.00 |
| 1036F | 0% | 3,141 | $0.00 | |
| 3044F | 0% | 343 | $0.00 | |
| 3079F | 0% | 1,274 | $0.00 | |
| 3017F | 0% | 592 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 27 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 211 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 368 | $0.00 |
| 1006F | 0% | 372 | $0.00 | |
| 1125F | 0% | 43 | $0.00 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | 0% | 165 | $0.00 |
| 3075F | 0% | 192 | $0.00 | |
| 3014F | 0% | 21 | $0.00 | |
| 1101F | 0% | 16 | $0.00 | |
| 3025F | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKARR, AARON (MANANGING PARTNER)
| Provider | Location | Paid |
|---|---|---|
| Safe Harbor of the Shoals, INC | Tuscumbia, AL | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.